Jmx Medical Institution And Research Center Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 7.65 Cr
as on 13-12-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 23.10 Cr
as on 13-12-2024
- Revenue 92.77%
(FY 2023)
- Profit 77.25%
(FY 2023)
- Ebitda 134.09%
(FY 2023)
- Net Worth 6.32%
(FY 2023)
- Total Assets 48.95%
(FY 2023)
About Jmx Medical Institution And Research Center
The Corporate was formerly known as Jiomax Medical Institution And Research Center Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.65 Cr.
The company currently has active open charges totaling ₹23.10 Cr.
Tejas Jariwala and Sarita Sharma serve as directors at the Company.
- CIN/LLPIN
U85100GJ2021PTC124313
- Company No.
124313
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jmx Medical Institution And Research Center?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tejas Jariwala  | Director | 22-Jul-2021 | Current |
| Sarita Sharma | Director | 15-Sep-2021 | Current |
Financial Performance and Corporate Structure Insights of Jmx Medical Institution And Research Center.
Jmx Medical Institution And Research Center Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 92.77% increase. The company also saw a substantial improvement in profitability, with a 77.25% increase in profit. The company's net worth moved up by a moderate rise of 6.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jmx Medical Institution And Research Center?
In 2023, Jmx Medical Institution And Research Center had a promoter holding of 12.65% and a public holding of 87.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ratandeep Hospitals & Medical Research C Entre LlpActive 6 years 7 monthsTejas Jariwala is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Aug 2023 | ₹20.00 Cr | Open |
Hdfc Bank Limited Creation Date: 10 Jan 2023 | ₹3.10 Cr | Open |
How Many Employees Work at Jmx Medical Institution And Research Center?
Jmx Medical Institution And Research Center has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jmx Medical Institution And Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jmx Medical Institution And Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
